Meeder Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Meeder Asset Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13,547	Closed	-$39K	–	2518
2020 Q2	$39K	Sell	13,547 -6,215	-31%	-$19.7K	﹤0.01%	978
2020 Q1	$55K	Buy	19,762 +867	+5%	+$2.79K	﹤0.01%	883
2019 Q4	$62K	Buy	+18,895	New	+$54.9K	﹤0.01%	962
2019 Q3	–	Sell	-27,671	Closed	-$87K	–	2371
2019 Q2	$87K	Sell	27,671 -4,082	-13%	-$13.2K	0.01%	794
2019 Q1	$117K	Sell	31,753 -9,895	-24%	-$33.4K	0.01%	660
2018 Q4	$120K	Sell	41,648 -15,702	-27%	-$43.1K	0.01%	596
2018 Q3	$151K	Buy	57,350 +24,925	+77%	+$61.2K	0.01%	551
2018 Q2	$75.9K	Buy	32,425 +22,579	+229%	+$63K	0.01%	676
2018 Q1	$28K	Buy	9,846 +4,133	+72%	+$11.3K	﹤0.01%	809
2017 Q4	$16K	Buy	5,713 +2,251	+65%	+$6.91K	﹤0.01%	1013
2017 Q3	$12K	Hold	3,462	–	–	﹤0.01%	1052
2017 Q2	$9K	Buy	+3,462	New	+$7.96K	﹤0.01%	1046
2016 Q3	–	Sell	-79,817	Closed	-$251K	–	1084
2016 Q2	$251K	Hold	79,817	–	–	0.02%	543
2016 Q1	$266K	Sell	79,817 -40,821	-34%	-$127K	0.03%	529
2015 Q4	$427K	Buy	120,638 +113,840	+1,675%	+$476K	0.04%	381
2015 Q3	$34K	Buy	+6,798	New	+$39K	﹤0.01%	630
2015 Q1	–	Sell	-44,045	Closed	-$339K	–	615
2014 Q4	$339K	Buy	+44,045	New	+$349K	0.04%	356

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Meeder Asset Management's PDLI Position: Q3 2020 in Review

Meeder Asset Management sold out of PDL BioPharma, Inc. (PDLI) in Q3 2020, closing a stake of 13,547 shares — an estimated $39K sold.

Meeder Asset Management first reported a position in PDLI in Q4 2014 and held it in 17 quarters. The position peaked at $427K in Q4 2015. 132 funds tracked by Wall St. Rank hold PDLI as of Q3 2020.

Meeder Asset Management reported no remaining PDL BioPharma, Inc. position as of Q3 2020 after selling out during the quarter.
Meeder Asset Management sold 13,547 PDL BioPharma, Inc. shares in Q3 2020, an estimated $39K.
Meeder Asset Management first reported a position in PDL BioPharma, Inc. in Q4 2014 and held it in 17 quarters.
Meeder Asset Management's PDL BioPharma, Inc. position peaked at $427K in Q4 2015.
132 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2020.

Based on Meeder Asset Management's 13F filing for Q3 2020, filed 2 Nov 2020.